{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:42:50Z","timestamp":1778892170206,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"am","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002287","name":"Progeria Research Foundation","doi-asserted-by":"publisher","award":["PRF2002-CB"],"award-info":[{"award-number":["PRF2002-CB"]}],"id":[{"id":"10.13039\/100002287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002287","name":"Progeria Research Foundation","doi-asserted-by":"publisher","award":["PRFCLIN2007-02"],"award-info":[{"award-number":["PRFCLIN2007-02"]}],"id":[{"id":"10.13039\/100002287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002287","name":"Progeria Research Foundation","doi-asserted-by":"publisher","award":["PRFCLIN2009-03"],"award-info":[{"award-number":["PRFCLIN2009-03"]}],"id":[{"id":"10.13039\/100002287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1RC2HL101631-0"],"award-info":[{"award-number":["1RC2HL101631-0"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Clinical and Translational Science Center","doi-asserted-by":"publisher","award":["UL1 TR001102"],"award-info":[{"award-number":["UL1 TR001102"]}],"id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bone.2019.05.008","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T23:08:49Z","timestamp":1557356929000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome"],"prefix":"10.1016","volume":"125","author":[{"given":"C.M.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Baltrusaitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Sr","given":"R.B.","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.T.","family":"Braddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.","family":"Kieran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.B.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.05.008_bb0005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00247-012-2423-1","article-title":"A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome","volume":"42","author":"Cleveland","year":"2012","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bone.2019.05.008_bb0010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/jbmr.392","article-title":"Hutchinson-Gilford progeria is a skeletal dysplasia","volume":"26","author":"Gordon","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.05.008_bb0015","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/CIRCULATIONAHA.112.000571","article-title":"Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment","volume":"127","author":"Villa-Bellosta","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2019.05.008_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and course of Hutchinson-Gilford progeria syndrome","volume":"358","author":"Merideth","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2019.05.008_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.113.008285","article-title":"Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome","volume":"130","author":"Gordon","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2019.05.008_bb0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2019.05.008_bb0035","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson-Gilford progeria","volume":"300","author":"De Sandre-Giovannoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bone.2019.05.008_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/HYPERTENSIONAHA.111.180919","article-title":"Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome","volume":"59","author":"Gerhard-Herman","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bone.2019.05.008_bb0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamacardio.2017.5235","article-title":"Cardiac abnormalities in patients with Hutchinson-Gilford progeria syndrome","volume":"3","author":"Prakash","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bone.2019.05.008_bb0050","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1253\/circj.CJ-11-0477","article-title":"Calcium phosphate deposition with normal phosphate concentration","volume":"75","author":"Villa-Bellosta","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.bone.2019.05.008_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.116.022188","article-title":"Clinical trial of the protein farnesylation inhibitors lonafarnib, pravastatin, and zoledronic acid in children with Hutchinson-Gilford progeria syndrome","volume":"134","author":"Gordon","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2019.05.008_bb0060","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2019.05.008_bb0065","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/art.22158","article-title":"Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation","volume":"54","author":"Pachman","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2019.05.008_bb0070","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0006-3495(91)82113-0","article-title":"Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals","volume":"60","author":"Pleshko","year":"1991","journal-title":"Biophys. J."},{"key":"10.1016\/j.bone.2019.05.008_bb0075","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1177\/0003702818789165","article-title":"Validated approaches for quantification of bone mineral crystallinity using transmission Fourier transform infrared (FT-IR), attenuated total reflection (ATR) FT-IR, and Raman spectroscopy","volume":"72","author":"Querido","year":"2018","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.bone.2019.05.008_bb0080","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3899\/jrheum.090833","article-title":"Calcification in a case of circumscribed myositis ossificans","volume":"37","author":"Ibarra","year":"2010","journal-title":"J. Rheumatol."},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2019.05.008_bb0085","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2019.05.008_bb0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/03009742.2016.1219766","article-title":"X-ray diffraction analysis of spontaneously draining calcinosis in scleroderma patients","volume":"46","author":"Hsu","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bone.2019.05.008_bb0095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/rej.2007.0649","article-title":"Clinical outcome and mechanism of soft tissue calcification in Werner syndrome","volume":"11","author":"Honjo","year":"2008","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.bone.2019.05.008_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11914-015-0254-3","article-title":"Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action","volume":"13","author":"Folsom","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2019.05.008_bb0105","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/jbmr.2870","article-title":"Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome","volume":"31","author":"Ramnitz","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.05.008_bb0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/pr.2018.9","article-title":"Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib","volume":"83","author":"Gordon","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2019.05.008_bb0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.morpho.2016.01.004","article-title":"Fibrodysplasia ossificans progressiva. A case report and focus on the BMP signaling pathway","volume":"100","author":"Bouvard","year":"2016","journal-title":"Morphologie"},{"key":"10.1016\/j.bone.2019.05.008_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1566524016666151222142446","article-title":"Development of new therapeutic agents for fibrodysplasia ossificans progressiva","volume":"16","author":"Luo","year":"2016","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bone.2019.05.008_bb0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.39440.525752.BE","article-title":"Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial","volume":"336","author":"Bolland","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2019.05.008_bb0130","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2019.05.008_bb0135","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Bolland","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2019.05.008_bb0140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.3375","article-title":"Calcium and vitamin D supplementation are not associated with risk of incident ischemic cardiac events or death: findings from the UK biobank cohort","volume":"33","author":"Harvey","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.05.008_bb0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/RHU.0000000000000264","article-title":"Recovery of severe muscular and fascial calcinosis after treatment with bisphosphonates in a child with juvenile dermatomyositis","volume":"21","author":"Canas","year":"2015","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.bone.2019.05.008_bb0150","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1600-0625.2012.01553.x","article-title":"Restricting dietary magnesium accelerates ectopic connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6\u2212\/\u2212)","volume":"21","author":"Jiang","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bone.2019.05.008_bb0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.actbio.2015.08.042","article-title":"Effects of extracellular magnesium extract on the proliferation and differentiation of human osteoblasts and osteoclasts in coculture","volume":"27","author":"Wu","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bone.2019.05.008_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1752-8062.2011.00390.x","article-title":"Magnesium reduces carotid intima-media thickness in a mouse model of pseudoxanthoma elasticum: a novel treatment biomarker","volume":"5","author":"Kupetsky-Rincon","year":"2012","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bone.2019.05.008_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2005.06.017","article-title":"The BMP signaling and in vivo bone formation","volume":"357","author":"Cao","year":"2005","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.bone.2019.05.008_bb0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11914-017-0370-3","article-title":"Inherited arterial calcification syndromes: etiologies and treatment concepts","volume":"15","author":"Nitschke","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2019.05.008_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bone.2019.05.008_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002499","article-title":"Transgenic overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in vascular endothelium results in generalized arterial calcification","volume":"4","author":"Savinov","year":"2015","journal-title":"J. Am. Heart Assoc."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:42:54Z","timestamp":1757612574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219301723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"alternative-id":["S8756328219301723"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.05.008","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}